期刊
GYNECOLOGIC ONCOLOGY
卷 88, 期 1, 页码 73-79出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1006/gyno.2002.6851
关键词
Src; Yes; tyrosine kinase; ovarian cancer; immunohistochemistry; monoclonal antibody
资金
- NATIONAL CANCER INSTITUTE [R01CA039930, R01CA065527] Funding Source: NIH RePORTER
- NCI NIH HHS [CA65527, CA63617, CA39930] Funding Source: Medline
Objective. The objective of this study was to determine if the Src tyrosine kinase is overexpressed and activated in late-stage human ovarian cancers. Methods. Western analysis and immune complex kinase assays were performed on a panel of human ovarian cancer cell lines and normal ovarian epithelial cell cultures, and immunohistochemical analysis for Src and activated Src were performed on a panel of late-stage human ovarian tumors. Results and conclusions. Src is overexpressed and activated in a majority of late-stage ovarian tumors as well as in a panel of cultured malignant human ovarian epithelium grown in vitro, but not in normal ovarian epithelium (NOE) or immortalized NOE. Src overexpression was found to be frequently, but not always, associated with HER-2/neu overexpression, but no statistical association between Src and Her-2/neu overexpression could be demonstrated. (C) 2002 Elsevier Science (USA).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据